Oaktree Specialty Lending Corporation is a business development company.
FAIL · Does not pass the screen
13.06 USD
At the last full screen 2026-09-07
Screened 2026-09-07 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markdown label.
Oaktree Specialty Lending Corporation holds its Markdown at $13.06. Elevated stress, defensive posture warranted, held for 10 days.
As held on the ledger · 2026-09-07
Phase
Markdown · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 10 days
Price at the screen
$13.06
Valuation
27.21 trailing · 9.56 forward price to earnings
Values screen
FAIL· score 30.0
Beta
0.57
The Workings
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: financial services
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Prohibited keyword in sector/industry: financial services
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-07 screen. The gold marker is the market price at the same screen. A 3.4% margin of safety to the base estimate.
Third-party analyst targets: 6 covering, consensus None. The average target sits −4% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-07 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Debt fund blocked before numbers even matter
Picture a middle market lender handing out loans to companies that banks overlook. Oaktree Specialty Lending does exactly that yet never clears the first gate. Its sector alone triggers the ethical screen, so the investment case stops there regardless of any margin of safety or analyst target.
The figures reinforce the decision to pass. Revenue is shrinking 9 percent, return on equity sits at just 3 percent, and forward earnings trade at 8.9 times while growth remains negative. A business development company with thin profitability and no visible moat offers little reason to look past the ethical block.
Risk sits in the combination of cyclical credit exposure and structural headwinds common to specialty lenders. Low returns and shrinking revenue can persist even when multiples appear modest. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
OCSL trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 7%. The street (6 analysts) rates it none, with a mean price target of $12.
2026-08-07Markup · changed$12.13+0.0%Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 7%. The street (6 analysts) rates it none, with a mean price target of $12.
2026-07-18Distribution$12.13+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 6%. Our forward projection puts the odds of a 10% gain over the next month near 7%. The street (6 analysts) rates it none, with a mean price target of $12.
2026-07-03Distribution$12.13+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Distribution$12.13Entry 1
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
